Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017

GlobeNewswire February 16, 2017

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire February 15, 2017

CORRECTING and REPLACING Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Galena Biopharma, Inc.

Business Wire February 15, 2017

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. (GALE) To Contact Brower Piven Before The Lead Plaintiff Deadline

GlobeNewswire February 15, 2017

INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire February 15, 2017

Robbins Arroyo LLP: Galena Biopharma, Inc. (GALE) Misled Shareholders According to a Recently Filed Class Action

Business Wire February 14, 2017

SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm

Business Wire February 14, 2017

Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

GlobeNewswire February 13, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017

PR Newswire February 13, 2017

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Galena Biopharma, Inc. Investors

Business Wire February 13, 2017

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Galena Biopharma, Inc.

Business Wire February 13, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Galena Biopharma Inc. and Encourages Investors to Contact the Firm

Business Wire February 10, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galena Biopharma, Inc. - GALE

PR Newswire February 10, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Galena Biopharma Inc. and Encourages Investors to Contact the Firm

Business Wire February 10, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galena Biopharma, Inc. (GALE)

PR Newswire February 10, 2017

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Galena Biopharma, Inc. – GALE

Business Wire February 10, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Galena Biopharma Inc. and Advises Investors with Losses to Contact the Firm

Business Wire February 9, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Galena Biopharma, Inc. Investors

Business Wire February 9, 2017

Mid-Afternoon Market Update: Walker & Dunlop Gains After Q4 Results; SPS Commerce Shares Tumble

Benzinga.com  February 8, 2017

20 Biggest Mid-Day Losers For Wednesday

Benzinga.com  February 8, 2017